RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million
AI Summary
RegenLab announced plans for a Nasdaq listing under the ticker RGNA after surpassing $29 million in revenues. The company's move to go public marks a significant development in its financial growth and visibility in the biotech sector.